Surunkali leykozni zamonaviy davolash usullari

Authors

  • O‘ktamov Dilxushbek Olimjon o‘g‘li Toshkent tibbiyot akademiyasi 3-bosqich talabasi

Keywords:

Surunkali leykoz, target terapiya, immunoterapiya, transplantatsiya, standar kimyoterapiya, tirozin kinaza ingibitorlari.

Abstract

Surunkali leykozni davolashni to’g’ri yo’lga qo’yish, unga tasir
qiluvchi dori vositalari va ularning samarasini o’rganish. Dori narxlari bilan tanishib
chiqish, qaysi davlatda davolanishga qarab ketadigan pul mablag’lagi va qaysi davlatlarda
samarali davo topish, onkolog shifokorlarga bemorlarni davolash uchun to’plagan
malumotlar orqali eng qulay va to’g’ri yo’lni tanlashga ko’maklashish.

References

American Cancer Society (ACS). Chronic Leukemia Treatment Guidelines.

www.cancer.org (https://www.cancer.org/)

British Journal of Haematology (BJH). https://bjh.onlinelibrary.wiley.com

(https://bjh.onlinelibrary.wiley.com/)

DeVita, V.T., Hellman, S., & Rosenberg, S.A. (2021).

FDA Approved Drugs for Leukemia. www.fda.gov (https://www.fda.gov/)

Hoffman, R., et al. (2018). Hematology: Basic Principles and Practice. Elsevier.

Vol.2 №12 (2024). December

Journal of Effective

innovativepublication.uz

Learning and Sustainable Innovation

Medscape: Chronic Leukemia Overview and Management. www.medscape.com

(https://www.medscape.com/)

National Comprehensive Cancer Network (NCCN). www.nccn.org

(https://www.nccn.org/)

Rohit Kumar et al. (2020). www.jhoonline.org (https://jhoonline.biomedcentral.com/)

UpToDate. Management of Chronic Myeloid Leukemia. www.uptodate.com

(https://www.uptodate.com/)

World Health Organization (WHO). WHO. www.who.int (https://www.who.int/)

Downloads

Published

2024-12-06

How to Cite

O‘ktamov Dilxushbek Olimjon o‘g‘li. (2024). Surunkali leykozni zamonaviy davolash usullari. SAMARALI TA’LIM VA BARQAROR INNOVATSIYALAR JURNALI, 2(12), 142–150. Retrieved from https://innovativepublication.uz/index.php/jelsi/article/view/2049